首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1608826

小分子注射劑市場：按藥物類別、按適應症、按給藥方式、按最終用戶、按地區

Small Molecule Injectable Drugs Market, By Drug Class, By Indication, By Mode of Delivery, By End User, By Geography

出版日期: 2024年11月04日 | 出版商:

Coherent Market Insights | 英文 408 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

小分子注射劑市場預計到2024年將達到2,167.3億美元，預計到2031年將達到3,750.5億美元，2024年至2031年的複合年成長率為8.1%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	2167.3億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	8.10%	預計金額（2031年）	3750.5億美元

圖：2024 年小分子注射液市場佔有率（%），依地區分類

慢性病的流行和對藥物輸送系統的需求不斷增加正在推動小分子注射劑市場的發展。小分子藥物與生技藥品和生物相似藥相比具有較小的分子量和不同的化學和物理性質。它可以透過多種途徑給藥，包括靜脈注射、肌肉注射和皮下注射。與傳統注射劑相比，小分子注射劑的優點包括控制釋放、提高穩定性和提高生物有效性。小分子注射劑的各種治療應用包括癌症、感染疾病、自體免疫疾病、心血管疾病等。此外，藥物傳輸技術的進步，特別是難溶性藥物和自行給藥裝置的進步，正在進一步擴大該市場的範圍。

市場動態：

全球小分子注射劑市場的推動因素包括各種慢性和危及生命的疾病的日益流行、越來越多的老年人口更容易患此類疾病，以及某些治療方法對注射劑相對於口服藥物的日益偏好。偏好。然而，注射劑藥物核准的嚴格監管政策和流程、研發和臨床試驗相關的高成本以及與注射給藥相關的安全問題是限制市場成長的一些因素。市場參與企業有機會提供先進的標靶藥物輸送系統，開發注射劑選擇有限的治療方法配方，並專注於擁有大量患者群體的新興經濟體。

本研究的主要特點

本報告對全球小分子注射劑市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和平均年成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球小分子注射劑市場的主要企業進行了分析。

主要公司包括諾華公司、輝瑞公司、Sun Pharmaceutical Industries Ltd.、Merck &Co, Inc.、Teva Pharmaceutical Industries Ltd.、Aurobindo Pharma Ltd.、Baxter、Fresenius Kabi AG、Cipla、Mylan NV、AstraZeneca，其中包括GSK plc、 Hikma Pharmaceuticals PLC、Ascletis Pharma Inc. 和Regeneron Pharmaceuticals Inc.

從這份報告中獲得的見解使負責人和公司經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。

全球小分子注射劑市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球小分子注射劑市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	216.73 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.10%	2031 Value Projection:	375.05 Bn

The growing prevalence of chronic diseases and rising demand for targeted drug delivery systems are fueling the small molecule injectable drugs market. Small molecule drugs have lower molecular weight and different chemical and physical properties compared to biologics and biosimilars. They can be administered through various routes such as intravenous, intramuscular, and subcutaneous injections. The advantages of small molecule injectable drugs over conventional injectables include controlled release of drugs, improved stability, and enhanced bioavailability. Various therapeutic applications of small molecule injectables include cancer, infectious diseases, autoimmune disorders, and cardiovascular diseases. Additionally, advancements in drug delivery technologies especially for poorly soluble drugs and self-administrable devices are further expanding the scope of this market.

Market Dynamics:

The global small molecule injectable drugs market is driven by the increasing incidence of various chronic and life-threatening conditions, growing geriatric population susceptible to such diseases, and rising preference for injectables over oral drugs in certain therapies. However, stringent regulatory policies and processes for the approval of injectable drugs, high costs associated with R&D and clinical trials, and safety issues related to drug administration through injections are some of the factors restraining the market growth. The market players have opportunities to offer advanced and targeted drug delivery systems, develop formulations for therapies having limited injectable options, and focus on emerging economies with large patient pools.

Key Features of the Study:

This report provides in-depth analysis of the global small molecule injectable drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global small molecule injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Baxter, Fresenius Kabi AG, Cipla, Mylan N.V, AstraZeneca, GSK plc, Hikma Pharmaceuticals PLC, Ascletis Pharma Inc., and Regeneron Pharmaceuticals Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global small molecule injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule injectable drugs market

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
- Small Molecule Antibiotics
- Chemotherapy Agents
- Skeletal Muscle Relaxants
- Analgesics
- Anticoagulants
- Anticonvulsants
- Antivirals
- Others (Anti-histamines/Anti-allergy, etc.)
Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Pain Management
- Cardiovascular Diseases
- Infectious Diseases
- CNS Diseases
- Others
Mode of Delivery Insights (Revenue, USD Bn, 2019 - 2031)
- Intravenous
- Intramuscular
- Subcutaneous
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Clinics
- Outpatient Facility
- Infusion Therapy Center
- Others (Home Care Settings, etc.)
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- Baxter
- Fresenius Kabi AG
- Cipla
- Mylan N.V
- AstraZeneca
- GSK plc
- Hikma Pharmaceuticals PLC
- Ascletis Pharma Inc.
- Regeneron Pharmaceuticals Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Small Molecule Injectable Drugs Market, By Drug Class
- Small Molecule Injectable Drugs Market, By Indication
- Small Molecule Injectable Drugs Market, By Mode of Delivery
- Small Molecule Injectable Drugs Market, By End User
- Small Molecule Injectable Drugs Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends
Key Developments

4. Small Molecule Injectable Drugs Market, By Drug Class, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Small Molecule Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Chemotherapy Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Skeletal Muscle Relaxants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Anti-histamines/Anti-allergy, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Small Molecule Injectable Drugs Market, By Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CNS Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Small Molecule Injectable Drugs Market, By Mode of Delivery, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Small Molecule Injectable Drugs Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Outpatient Facility
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infusion Therapy Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Home Care Settings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Small Molecule Injectable Drugs Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma Ltd.
Baxter
Fresenius Kabi AG
Cipla
Mylan N.V
AstraZeneca
GSK plc
Hikma Pharmaceuticals PLC
Ascletis Pharma Inc.
Regeneron Pharmaceuticals Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

小分子藥物發現市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按治療領域、製程/階段和地理位置

小分子藥物發現的全球市場：按治療領域、製程、最終用戶和地區分類

全球小分子 CDMO 市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

小分子CDMO市場規模、佔有率和趨勢分析報告：按產品、藥物類型、應用、地區和細分市場預測，2024-2030年

FAQ

小分子注射劑市場：按藥物類別、按適應症、按給藥方式、按最終用戶、按地區